CD40 and neoplasm: These results were based on the ability of the CD40 antibody to enhance antigen presentation, deplete the desmoplastic stroma, and ultimately promote antitumouricidal activities of monocytes, macrophages, and CD8+ T cells before their recruitment to the tumour site [96, 97].